Wanbury Ltd.

54.20 -2.67 ▼-4.7%

08 June 2023, 04:01:00 PM
Volume: 2,923

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.wanbury.com
Market Cap 178.28 Cr.
Enterprise Value(EV) 233.20 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 21.75 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 2.49 Trailing Twelve Months Ending 2022-12
Industry PE 33.65 Trailing Twelve Months Ending 2022-12
Book Value / Share -11.02 Trailing Twelve Months Ending 2022-12
Price to Book Value -4.92 Calculated using Price: 54.20
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 3.27 Cr. 32,705,498 Shares
FaceValue 10
About Wanbury Ltd.
Wanbury was incorporated in 1990 as a private limited company under the name of Pearl Distributors Private Limited. The name of the company was changed to 'Pearl Organics Private Limited on January 17, 1991 and the company was converted into a public limited company on August 6, 1991.

Wanbury Ltd. Delivery

Delivered Qty
Traded Qty

Wanbury Ltd. Performance

1 Day
-4.69%
1 Week
+10.66%
1 Month
+8.53%
3 Month
+46.96%
6 Month
+7.33%
1 Year
-15.38%
2 Year
-47.51%
5 Year
+92.20%
10 Year
+148.62%

Wanbury Ltd. Fundamental Ratios

9 years 2014-09 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%)
Return on Capital Employed (%) -31.06 13.85 15.27 70.48 -2.00 50.26 444.45 87.61 428.79
Return on Assets (%) -21.66 0.80 -1.82 15.57 -9.44 -9.00 23.10 -4.51 25.85

Wanbury Ltd. Balance Sheet

Particulars 10 years 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds -192 -194 -189 -153 -185 -209 -143 -156 -23 -31
Non Curr. Liab. 312 298 251 160 106 130 108 84 11 10
Curr. Liab. 259 265 299 402 348 362 311 355 360 360
Minority Int. 27 27 27
Equity & Liab. 406 396 388 409 269 283 275 284 347 338
Non Curr. Assets 219 215 224 217 192 185 182 182 174 174
Curr. Assets 187 181 164 192 78 98 94 98 171 165
Misc. Exp. not W/O
Total Assets 406 396 388 409 269 283 275 284 347 338

Wanbury Ltd. Profit and Loss

Particulars 10 years 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 662 250 423 434 371 391 367 393 511 501
Other Income 11 6 1 90 77 12 46 5 5 4
Total Income 673 256 425 524 448 403 414 397 516 505
Total Expenditure -638 -229 -391 -415 -439 -378 -389 -377 -479 -479
PBIDT 35 28 34 108 9 25 25 20 37 25
Interest -48 -19 -32 -36 -31 -40 -33 -23 -21 -19
Depreciation -23 -5 -9 -10 -10 -10 -10 -10 -11 -12
Taxation -3 -1 0 0 0 0 0 0 0
Exceptional Items -89 83 76 76
PAT -128 3 -7 62 -32 -25 64 -13 81 71
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -128 3 -7 62 -32 -25 64 -13 81 71
Adjusted EPS -64 2 -4 27 -13 -10 26 -5 25 22

Wanbury Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 87 68 40 43 43 32 30 44 17 41
Cash Fr. Inv. -21 -6 -5 -20 -13 -1 -3 64 8 1
Cash Fr. Finan. -64 -71 -30 -28 -27 -33 -27 -108 -17 -29
Net Change 3 -9 5 -5 3 -2 0 0 7 13
Cash & Cash Eqvt 10 1 6 2 5 3 3 3 10 23

Wanbury Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 52.09 39.90 39.90 39.89 39.89 39.85 39.85 39.84 39.84
Public 47.91 60.10 60.10 60.11 60.11 60.15 60.15 60.16 60.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 76.76 76.76 76.76 76.76 76.76 76.74 76.74 0.00 0.00

Wanbury Ltd. Announcements

Wed, 07 Jun 2023
Board Meeting Intimation for Notice For Re-Schedulement Of Board Meeting For Approving Audited Financial Statements And Results Of The Company For The Fourth Quarter And Year Ended 31St March 2023.
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2023 inter alia to consider and approve Further to our letter dated 22nd May 2023 and 25th May 2023 on the captioned subject Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited which was deferred and scheduled to be held on Friday 9th June 2023 is now postponed and further re-scheduled to be held on Friday 30th June 2023 due to some unforeseen and unavoidable circumstances inter-alia to consider and approve the Audited Financial Statement & Results (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March 2023.
Wed, 07 Jun 2023
Corrigendum To The Intimation Of The Board Meeting
With reference to the above captioned subject and in furtherance to our intimation dated 22nd May 2023 and 25th May 2023 notice is hereby given that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the meeting of the Board of Directors of Wanbury Limited which was deferred and scheduled to be held on Friday 9th June 2023 is now postponed and further re-scheduled to be held on Monday 26th June 2023 due to some unforeseen and unavoidable circumstances inter-alia to consider and approve the Audited Financial Statement & Results (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March 2023.Kindly note the date of the Board Meeting is submitted inadvertently as 30th June 2023 instead of 26th June 2023.
Wed, 07 Jun 2023
Board Meeting Intimation for Notice For Re-Schedulement Of Board Meeting For Approving Audited Financial Statements And Results Of The Company For The Fourth Quarter And Year Ended 31St March 2023.
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2023 inter alia to consider and approve Further to our letter dated 22nd May 2023 and 25th May 2023 on the captioned subject Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and DisclosureRequirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited which was deferred and scheduled to be held on Friday 9th June 2023 is now postponed and further re-scheduled to be held on Monday 26th June 2023 due to some unforeseen and unavoidable circumstances inter-alia to consider and approve the Audited Financial Statement & Results (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March 2023.

Wanbury Ltd. Technical Scans

Thu, 08 Jun 2023
Closing Below Previous Low Closing Below Previous Low
Close Above Last Week High Close Above Last Week High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
William %R Bearish William %R Bearish

Wanbury Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,838.35 987.10 -2.7%
Divi's Laboratories Ltd. 92,904.71 3,499.65 -1.2%
Cipla Ltd. 77,933.48 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. 77,441.55 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. 70,842.70 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. 60,989.56 1,802.05 +0.0%
Mankind Pharma Ltd. 58,646.15 1,464.00 -1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.95 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2023-03 50.95 3,499.65 -1.2%
Cipla Ltd. Consolidated 2023-03 27.81 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.18 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.49 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.99 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2023-03 45.75 1,464.00 -1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,499.65 -1.2%
Cipla Ltd. Consolidated 2023-03 3.33 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.33 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.45 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.84 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2023-03 4.99 1,464.00 -1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,464.00 -1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,464.00 -1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,464.00 -1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,464.00 -1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,464.00 -1.5%

Wanbury Ltd. FAQ's

What is Wanbury share price?

Can I buy Wanbury shares now?

What is the Market Cap of Wanbury?

What are the key metrics to analyse Wanbury?

What is the 52 Week High and Low of Wanbury?

What is the trend of Wanbury share price?